Novartis Rydapt wins EU approval for AML, other diseases Ruby Khatun Khatun22 Sept 2017 9:57 AM ISTZURICH: Swiss drugmaker Novartis on Wednesday won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML)...
MTaI urges govt to look at sub-categorization of devices Ruby Khatun Khatun21 Sept 2017 11:01 AM ISTNew Delhi: The medical technology industry has reached out to the government to look at sub-sectoring and sub-categorization of medical devices on the...
Strides Shasun gets USFDA nod for lipid lowering drug Ruby Khatun Khatun21 Sept 2017 10:49 AM ISTNew Delhi: Drug firm Strides Shasun on Wednesday said it has received approval from the United States health regulator for generic Omega-3-acid ethyl...
Divis Labs gets 6 USFDA observations for Vizag unit Ruby Khatun Khatun21 Sept 2017 10:27 AM ISTNew Delhi: Drug firm Divis Laboratories on Thursday said it has received six new observations from the US Food and Drug Administration (USFDA) after...
Novartis Cosentyx sets new benchmark in psoriasis with robust 5-year sustained Phase III efficacy and safety data Ruby Khatun Khatun21 Sept 2017 9:57 AM ISTBasel, September 13, 2017 - Novartis announced, first of its kind Phase III data showing Cosentyx® (secukinumab) delivered high and long-lasting skin...
Cadila in pact with Russian firm for chickenpox vaccine Ruby Khatun Khatun20 Sept 2017 10:47 AM ISTNew Delhi: Drug firm Cadila Healthcare on Tuesday said it has signed a technology agreement with Russian firm Pharm Aid Ltd for production of...
Glenmark gets USFDA nod for generic skin ointment Ruby Khatun Khatun20 Sept 2017 10:17 AM ISTNew Delhi: Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market Desonide Ointment, used to treat...
Bayer to end non-US sales of Essure, a contested sterilisation implant Ruby Khatun Khatun20 Sept 2017 9:47 AM ISTParis: The pharmaceutical giant Bayer announced on Tuesday that it would end non-US sales of Essure, a sterilisation implant that in news reports has...
Biosimilar cancer drug threat closing in for Roche Ruby Khatun Khatun20 Sept 2017 9:28 AM ISTLONDON: The long-heralded threat of cut-price competition to its top-selling biological cancer medicines is finally becoming a reality for Roche, the...
Fosun Pharma to buy 74 percent stake in Gland Pharma for 1.1 billion dollar Ruby Khatun Khatun19 Sept 2017 10:47 AM ISTBEIJING/MUMBAI: Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 percent for $1.1...
Glenmark looks to file up to 25 product applications annually Ruby Khatun Khatun19 Sept 2017 10:19 AM ISTNew Delhi: Glenmark Pharmaceuticals plans to file close to 25 product applications annually over the next five years, the company's chairman has...
USFDA approves GSK three-in-one drug inhaler for COPD Ruby Khatun Khatun19 Sept 2017 9:57 AM ISTGlaxoSmithKline Plc (GSK) and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for the...
